Abstract. The Saccharomyces cerevisiae CDC42 gene product is involved in the morphogenetic events of the cell division cycle; temperature-sensitive cdc42 mutants are unable to form buds and display delocalized cell-surface deposition at the restrictive temperature (Adams, A. E. M., D. I. Johnson, R. M. Longnecker, B. E Sloat, and J. R. Pringle. 1990. J. Cell Biol. 111:131-142). To begin a molecular analysis of CDC42 function, we have isolated the CDC42 gene from a yeast genomic DNA library. The use of the cloned DNA to create a deletion of CDC42 confirmed that the gene is essential. Overexpression of CDC42 under control of the GALIO promoter was not grossly deleterious to cell growth but did perturb the normal pattern of selection of budding sites. Determination of the DNA and predicted amino acid sequences of CDC42 revealed a high degree of similarity in amino acid sequence to the ras and rho (Madaule, P., R. Axel, and A. M. Myers. 1987. Proc. Natl. Acad. Sci. 84:779-783) families of gene products. The similarities to ras proteins (,,~40% identical or related amino acids overall) were most pronounced in the regions that have been implicated in GTP binding and hydrolysis and in the COOH-terminal modifications leading to membrane association, suggesting that CDC42 function also involves these biochemical properties. The similarities to the rho proteins (~60% identical or related amino acids overall) were more widely distributed through the coding region, suggesting more extensive similarities in as yet undefined biochemical properties and functions.
T
rIE Saccharomyces cerevisiae CDC24, CDC42, and CDC43 gene products play critical roles in the establishment of cell polarity, the localization of secretion and cell-surface deposition, and the development of normal cell shape (Hartwell et al., 1974; Sloat and Pringle, 1978; Field and Schekman, 1980; Sloat et al., 1981; Pringle and Hartwell, 1981; Pringle et al., 1986; Adams et al., 1990) . Yeast strains carrying temperature-sensitive lethal mutations in these genes have essentially identical morphological phenotypes. At permissive temperatures, the mutants grow and bud normally; at restrictive temperatures, the nuclear cycle continues but bud formation is blocked. Cell mass and volume continue to increase, resulting in greatly enlarged, unbudded cells. The cytoplasmic actin network appears disorganized (Adams and Pringle, 1984; Adams et al., 1990) , and chitin and other cell surface materials appear to be deposited randomly or uniformly throughout the enlarging cell walls, in contrast to their normal highly localized patterns of deposition. In addition, some temperature-sensitive cdc24 mutants show abnormal positioning of budding sites when grown at permissive temperatures, suggesting that the CDC24 gene product is involved in the initial selection and organization of the budding site (Sloat et al., 1981) . Another cdc24 mutant was identified among a collection of calcium-D. I. Johnson's present address is Department of Microbiology and Molecular Genetics, University of Vermont, Burlington, VT 05405. sensitive mutants, suggesting a possible interaction of the gene product with calcium (Ohya et al., 1986a,b) . The CDC24 gene has been cloned Ohya et al., 1986a) and sequenced (Miyamoto et al., 1987) . The predicted gene product contains two putative Ca2+-binding domains.
As a step in the further analysis of this system, we have begun a molecular characterization of the CDC42 gene and its product. We report here the isolation and sequence analysis of CDC42, as well as the phenotypes associated with its deletion or overexpression. Remarkably, the predicted amino acid sequence of the CDC42 product is strikingly similar to the ras (Capon et al., 1983; Powers et al., 1984; Tatchell, 
DNA and RNA Manipulations
Standard procedures were used for recombinant DNA manipulations (Maniatis et al., 1982) , E. coli and yeast transformations (Maniatis et al., 1982; Hinnen et al., 1978) , plasmid isolation from E. coli (Birnboim and Doly, 1979) and yeast (Sherman et al., 1986) , and nick translations using 32p-dATP (Maniatis et al., 1982) . Total yeast DNA was isolated essentially as described previously (Bloom and Carbon, 1982) . Total RNA was prepared from strain C276-4A growing exponentially in the rich, glucose-contaming medium YM-P (LiUie and Pringle, 1980) essentially as described by Maccecchini et al. (1979) . Poly(A)-containing RNA was then isolated by chromatography on poly(U)-Sephadex (Bethesda Research Laboratories, Gaithersburg, MD), following the manufacturer's instructions. DNA and RNA blot hybridizations were performed essentially as described previously (Maniatis et al., 1982; Thomas, 1980) , using 1% agarose gels and nitrocellulose paper. The DNA-DNA hybridizations were performed at 65°C for ,,o16 h in a solution containing 5 × SSC salts (Maniatis et al., 1982) and 1% sarkosyl. The RNA-DNA hybridizations were performed at 42°C for ",,16 h in 50 mM sodium phosphate buffer, pH 7, containing 5× SSC salts, 250 #g/ml calf thymus DNA, 0.02% bovine serum albumin, 0.02% FicoU 400, 0.02% polyvinylpyrollidone, and 50% formamide.
MI 3 dideoxy sequencing (Sanger et al., 1977) was performed essentially as described in the Bethesda Research Laboratories M13 sequencing manual, using 35S-dATP and the vectors M13mp8, M13mplS, and M13mpl9. Exonuclease III generation of M13 deletion derivatives used in dideoxysequencing reactions was performed using a modification (Beltzer et al., 1986) of the procedure of Henikoff (1984) . The mutagenic oligonucleotide GAGACCCTAGTCATAT (the underlined A is T in the wild-type sequence) and certain sequencing primers were provided by The University of Michigan Center for Molecular Genetics Oligonucleotide Synthesis Facility (Ann Arbor, MI). Site-directed mutagenesis (Kunkel, 1985) was performed using the MUTA-GENE TM kit from Bio-Rad Laboratories (Richmond, CA), following the supplier's instructions.
The mTn3 (URA3) minitransposon (Seifert et al., 1986) was used for insertional inactivation of the CDC42 gene. The Sea I-Xba I fragment from pBR(42)l (see Results) and a fragment from YEp24 containing the 2-# plasmid origin of replication were inserted by standard procedures into plasmid pHSS6 (Seifert et al., 1986) to generate plasmid pHSS6(42)l. After cotransformation of pHSS6(42)l and a mTn3 (URA3) transposon-containing plasmid into the appropriate E. coli strain (Seifert et al., 1986) , cells that contained a mTn3(URA3) transposon inserted into pHSS6(42)1 were selected. The locations and orientations of the insertions were then determined relative to the Xho I and Pvu I sites of pHSS6(42)l by restrictionenzyme analysis (see Results).
Computer Programs
DNA sequences were analyzed on an IBM-compatible computer using the Pusteil sequence analysis programs (International Biotechnologies, Inc., New Haven, CT). Amino acid sequence similarities were determined using the Microgenie TM sequence-analysis programs (Beckman Instruments, Inc., Fullerton, CA).
Visualization of Chitin Rings
Plasmid-containing yeast cells were grown under conditions selective for the plasmid, with 2% glucose or 2% galactose as the sole carbon source. Chitin rings were visualized by fluorescence microscopy after staining cells in 0.1% Calcofluor for 3 rain and washing in distilled water (Sloat and Pringle, 1978) .
R e s u l t s Isolation and Identification of CDC42
Plasmids that complemented the temperature-sensitive cdc42ol mutation in strain DJTD2-16D were isolated from a yeast genomic-DNA library in the URA3-containing plasmid YEp24. 24 primary Ura + Ts + transformants were obtained. From each transformant, a plasmid was recovered into E. coli that could retransform DJTD2-16D to Ura + Ts +. The Ura + and "Is + phenotypes of these transformants cosegregated after growth on nonselective media (data not shown), indicating that the complementation of cdc42-1 was due to the autonomously replicating recombinant plasrnids.
Restriction enzyme analyses and D N A -D N A blot hybridization experiments (data not shown) indicated that all 24 plasmids contained overlapping regions of DNA. Several representative plasmids that were examined in more detail shared a common 2.7-kb region of DNA (Fig. 1 A) . D N A -D N A blot hybridization experiments using total yeast DNA and a probe derived from one of these plasmids revealed only the fragments expected if the cloned DNA was derived without rearrangement from contiguous chromosomal DNA that was single copy in the haploid genome ( Fig. 2 A, lanes 1-5) . The observation that all 24 complementing plasmids contained overlapping DNA inserts suggested that the CDC42 TGTGCCAAAG ACCTTTCAAA CAGGCCTTTA  -561  GCACTTTCTC TTTTTTTTTT AAAAAAAGTT  -491  TTTTGTATTG TAGACTGTTA GATAATCCAC  -421  ATTAAAGATG TCTTCCACCG TCGATTCAAG  -351  CCAAATGAAA CAAGATACGG GAAAAAGTAA  -281  AGACGCGATT CTTCGAAAAG GCAAGAGCAG  -211  ATTATCCTTC TCTGTCATTC TTCACTTTTT  -141  TTATIAIA~T ATTCTATTTT gene itself, rather than a plasmid borne suppressor, had been cloned. This hypothesis was supported by the observations that CDC42 maps to chromosome XII and that the cloned DNA hybridized to the chromosome XII band after orthogonal field alternation gel electrophoresis (Johnson et al., 1987) . To test further the identity of the cloned DNA, we integrated a plasmid containing cdc42-complementing sequences and the yeast selectable marker URA3 into a CDC42 ÷ yeast strain and then determined the meiotic linkage between the integrated URA3 gene and a cdc42 mutation. The 2.5-kb Xho I-Sal I fragment from plasmid pBR(42)l was inserted into the Sal I site of the URA3-containing plasmid YIp5 (which cannot replicate autonomously in yeast). The resulting plasmid was linearized within the insert at the unique Xba I site and transformed into strain TIM, selecting for Ura ÷. Two stable Ura ÷ transformants were shown by DNA-DNA blot hybridization to have the plasmid integrated at the chromosomal site homologous to the cdc42-complementing DNA (Fig. 2 A, lanes 5 and 6) . These transformants were crossed to the cdc42-1 strain DJMD2-7C. 80 of 84 four-spore tetrads were parental ditypes (2 Ura ÷ Ts+: 2 Ura-Ts-); the remaining four tetrads segregated 3 Ts÷: 1 Ts-. Thus, integration had indeed occurred at the CDC42 locus.
The recessive, temperature-sensitive lethal phenotype of the cdc42-1 mutation suggests that the CDC42 gene product is essential for vegetative growth. To test this conclusion and complete the identification of the cloned DNA, we generated a deletion mutation by replacing the cdc42-complementing region with the URA3 gene. The DNA between the unique Hpa I and Xba I sites in plasmid pBR(42)l (Fig. 1 A) was replaced with the URA3-containing Sma I-Spe I fragment from YEp24. A 2.5-kb Xho I-Spe I fragment, which contained the URA3 gene flanked on both sides by DNA from the cdc42-complementing region, was excised from the resuiting plasmid and used to transform the CDC42/cdc42 heterozygous diploid strain DJID7-1 to Ura +. Two stable Ura + Ts-transformants were shown by DNA-DNA blot hybridization to have sustained fragment replacement by the transforming sequences at the site homologous to the cdc42-complementing DNA (Fig. 2 B) . Dissection of 22 tetrads from these transformants yielded exclusively a segregation of 2 live, The Journal of Cell Biology, Volume 111, 1990 Figure 4 . DNA sequence of the region altered by site-directed mntagenesis. Mutagenesis was performed as described in Materials and Methods using M13mpl9 containing the 1.8-kb Sca I-Xba I fragment (see text) as template. The column of letters is the wildtype CDC42 sequence; the T to A transversion produced by mutagenesis is also indicated. Sequence 1 is of a control template that was not altered by the mutagenesis; note that the uppermost two bands in the G lane are "ghost bands" that were not present in other sequencing runs on control templates. Sequence 2 is of a template containing the mutation. The dideoxy nucleotide used in each sequencing reaction is indicated above the corresponding lane.
Ura-Ts-: 2 dead, showing that the insertion of URA3 had produced a lethal mutation that was at or near the CDC42 locus. Microscopic examination of the dead spore clones showed that they had undergone several rounds of cell division before arresting as large, unbudded cells (like the cdc42-1 ts mutant). Moreover, the Ts-phenotype of the original diploid transformants showed that the new lethal mutation failed to complement the cdc42-1 ~ mutation, providing further evidence that the bona fide CDC42 gene had been cloned.
Localization of CDC42 on the Complementing DNA
To localize the CDC42 gene, subclones were constructed as described in Fig. 1 A. Complementation of the cdc42-1 mutation by plasmids YRp(42)l and YRp(42)3, but not by YRp(42)2, indicated that CDC42 lies within the 1.6-kb Sca INde I region. Subclones derived from this region all failed to complement the cdc42-1 mutation (Fig. 1 B) . However, cdc42-1 cells transformed with plasmid YEp(42)3 yielded Ts + subclones at a frequency of ~10 -t when plated at 36°C. These subclones were stably Ts ÷ and Ura ÷ when grown under nonselective conditions, suggesting that integration of the plasmid had generated a complete, Ts ÷ copy of CDC42 from the complete, but mutant, copy originally in the chromosome and an incomplete, but otherwise wild-type, copy in the plasmid. Although the frequency of integration seemed surprisingly high (see Discussion), this result suggested strongly that the cdc42-1 mutation lies to the right of the Hpa I site. In contrast, cdc42-1 cells transformed with either plasmid YEp(42)4 or YEp(42)5 yielded Ts ÷ subclones at frequencies no greater than those observed with the control plasmid YEp24, indicating that recombination-mediated marker rescue could not occur. This result was surprising in view of the data (presented below) suggesting that these two fragments span the entire CDC42 coding region (see Discussion).
Localization of CDC42 was also attempted by determining the distribution of sites at which transposon insertion could inactivate cdc42-complementing activity. Transposon-containing plasmids were collected and analyzed as described in Materials and Methods, then tested for cdc42-complementing activity in strain DJTD2-16D. The results (Fig. 1 B) suggested that the CDC42 gene occupied a ~,0.9-kb region lying mostly between the Hpa I and Nde I sites.
Analysis of mRNA Transcripts
RNA-DNA blot hybridization using a probe spanning the cdc42-complementing region revealed only one major transcript ( Fig. 2 C, lane/) ~1 kb long (as judged by its comigration with the URA3 transcript; data not shown). A 14-fold longer exposure of the autoradiogram revealed a faint band corresponding to a transcript of ,'-, 3 kb, but did not reveal any additional transcripts of lower molecular weight ( 
Analysis of CDC42 Nucleotide and Predicted Amino Acid Sequences
The 1.8-kb Sca I-Xba I fragment from pBR(42)l was inserted into M13mpl8 and M13mpl9 that had been digested with Sma I and Xba I. These phages and appropriate deletion derivatives (see Materials and Methods) were then used in dideoxy-sequencing reactions. Both strands of the cdc42-complementing region between the Sca I and Nde I sites ( Fig. 1 B) were completely sequenced using this strategy (Fig. 3) . This analysis revealed the presence of eight ATGinitiated open reading frames (ORFs) ~ of >140 codons (Fig.  1 B) and no TACTAAC consensus splicing sequence (Langford et al., 1984) , suggesting an absence ofintrons. The various data presented above suggested strongly that the 191 codon ORF was the CDC42 gene, but did not completely eliminate the possibility that the 100 codon ORF on the other strand was responsible for CDC42 activity. To settle this point, we used site-directed mutagenesis to change the TTG L~u codon at nucleotides 208-210 of the 191 codon ORF (see Fig. 3 ) to a TAG nonsense codon (Fig. 4) . The corresponding change in the 100 codon ORF was from ACA TM to ACT TM at codon 2; as both of these threonine codons are used frequently (Bennetzen and Hall, 1982) , this change presumably would not affect the expression of the hypothetical 100 amino acid gene product. DNA sequence analyses showed the absence of any other nucleotide changes within the 191 codon or 100 codon ORFs. After mutagenesis and sequence analysis, the Xho I-Hind III fragment containing the CDC42 region (see Fig. 1 ; the Hind 1II site is next to the Xba I site in M13mpl9) was isolated from phage with and without the mutation and inserted into Sal I/Hind IIIdigested plasmid YEpl03. The resulting plasmids that contained the mutation were unable to complement the cdc42-1 mutation in strain DJTD2-16D. In contrast, two control plasmids that had been generated using the same procedure, but did not contain the mutation, retained cdc42-complementing activity. Thus, it seems clear that the 191 codon ORF encodes the CDC42 gene product. The predicted CDC42 product is a polypeptide of 191 amino acids with molecular weight of 21,356 and a net charge of +2 (Fig. 3) . Comparison of the amino acid sequence with the National Biomedical Research Foundation protein database revealed a high degree of similarity between the CDC42 product and members of the ms and rho families of gene products (Fig. 5) . For example, the CDC42 product is 30% identical (40% identical or related) in predicted amino acid sequence to the human H-ras product and comparably similar to the yeast RAS1 and RAS2 gene products. , 1989) . Interestingly, however, the highly conserved Ash and Lys residues at positions 116 and 117 of ms, which have been implicated in the guanine specificity of the nucleotide-binding site, are replaced by Thr and Gln in CDC42 (see also below). The similarities of CDC42 to the rho proteins are more extensive and more widely distributed through the coding regions. In particular, the CDC42 product is '~53% identical (~58% identical or related) to the human andAplysia rho gene products, 52% identical (61% identical or related) to the S. cerevisiae RIt01 gene product, and 37% identical (51% identical or related) to the S. cerevisiae RII02 gene product, which is itself 53% identical (66% identical or related) to the S. cerevisiae RII01 gene product. Although the available data are still limited, it appears that the closest homologue to CDC42 may be "G25K," a 25-kD GTP-binding protein that has been purified from several mammalian tissues ( 
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Expression of CDC42 under GALlO-promoter Control
Inspection of the CDC42 sequence revealed that the Hpa I site is at position -67 to -62 relative to the putative initiator ATG codon (Fig. 3) . This suggested that the lack of complementation and unusual marker-rescue results obtained with the Hpa I-Xba I fragment in plasmid YEp(42)3 (see above) might have reflected the presence of only an incomplete promoter in this fragment, a possibility consistent with the observation of potential TATA promoter sequences at positions -112 to -107 and -96 to -91 (see Fig. 3 ). To explore this possibility, the Hpa I-Xba I fragment from plasmid pBR(42)l was inserted into the Sal I site of plasmid YEp51 so that the 191 codon ORF should be under the control of the yeast galactose-inducible GALIO promoter in the resulting shuttle plasmid. This plasmid, YEp51(42), complemented the cdc42-1 mutation in strain DJMD22-3B when cells were grown on either 2 % glucose or 2 % galactose as the sole carbon source, as judged by the cells' ability to grow at a normal rate at 36°C. These results supported our interpretation of the results obtained with plasmid YEp(42)3 (see Discussion). However, even at 23°C, YEp51(42)-containing cells growing on either carbon source displayed abnormalities in their budding patterns, as revealed by the staining of bud scars with Calcofluor. In contrast to the normal unipolar budding pattern of haploid cells and bipolar budding pattern of diploid cells (Fig. 6 A and C; Sloat et al., 1981) , we observed apparently random budding patterns in ,~75% of YEp51(42)-containing DJMD22-3B and DJD1 cells grown under derepressing conditions (2% galactose) and ,~35% of YEp51(42)-containing DJMD22-3B cells grown under repressing conditions (2 % glucose) (Fig. 6, B and D) . (Note that only cells with two or more bud scars could be included in these counts; 100 such cells were counted in each case.) Only ,~10% of the haploid or diploid ceils containing YEp51 itself exhibited such budding patterns when growing on either galactose or glucose. However, similar abnormalities of budding pattern were also observed in "~50 % of DJTD2-16D cells containing the CDC42 gene on a 3.7-kb Barn HI-Sal I fragment (Fig.  1 A) inserted into the high-copy number plasmid YEpl03.
Discussion
The CDC42 gene product is involved in the morphogenetic steps of the yeast cell cycle. To begin exploring CDC42 function at the molecular level, we have isolated and sequenced this gene. All cdc42-complementing clones that we analyzed contained overlapping DNA segments, suggesting that the bona fide CDC42 gene had been isolated. This suggestion was confirmed by the findings that the isolated DNA segment could direct integration to the CDC42 locus and that deletion of this segment yielded a lethal mutation that failed to complement the cdc42-1 ~ mutation. Subcloning localized CDC42 to a 1.6-kb segment of DNA, the sequencing of which revealed several ORFs. The longest of these was identified as CDC42 by several lines of evidence, including the results of transposon and site-directed mutagenesis, the demonstration that a plasmid in which this ORF should be expressed under GALIO control could complement a cdc42-1 ~ mutation, and the demonstration that the putative CDC42 mRNA was transcribed from the strand appropriate for this ORE This mRNA was somewhat longer than expected from the size of the ORF, and it is conceivable that the actual CDC42 transcript is a lower abundance species that we did not detect. However, it seems more likely that the CDC42 transcript has unusually extensive untranslated regions at the 5' end, the 3' end, or both. Further work will be necessary to resolve these issues.
We obtained rather confusing results when we attempted to use recombination-mediated marker rescue (Patterson et al., 1986) to confirm that the bona fide CDC42 gene had been isolated and to localize the cdc42-1 ts mutation. Plasmid YEp(42)3 (Fig. 1 B) failed to complement the cdc424 t~ mutation but yielded Ts + recombinant subclones at the surprisingly high frequency of ~10%. As the insert in YEp(42)3 spans the entire CDC42 ORE the failure of complementation presumably results from the absence of an adequate promoter in the 64 bp of sequence 5' to the initiator ATG in this clone. This hypothesis is supported by the observation that the same fragment could complement the cdc424 '~ mutation when linked to the GALIO promoter. Interestingly, this complementation was observed both during growth on galactose and during growth on glucose, which should repress transcription from the GALIO promoter. Perhaps only a small amount of CDC42 mRNA is required and repression of the particular promoter construction used here (the GALIO promoter plus 64 bp of CDC42 upstream sequence) is incomplete during growth on glucose. In any event, similar effects have been observed by others (Broach, J., personal communication) .
The Ts + subclones observed with YEp(42)3 apparently resulted from integration of the entire plasmid. It is clear that such integration could generate a complete, normal copy of the gene, but it is unclear why the event occurred in such high frequency. Perhaps the DNA segment contains a hot spot for recombination, or the production of some normal CDC42 product (from a partially functional promoter in YEp(42)3) allows the cells to survive long enough at restrictive temperature that the chances of rescue by plasmid integration are increased. Alternatively, there could be selection for such integrants even during growth at the nominally "permissive" temperature (see Adams et al., 1990) .
In contrast, neither plasmid YEp(42)4 nor plasmid YEp(42)5 (Fig. 1 B) yielded Ts + recombinant transformants at a frequency detectably above control values, although the inserts of these plasmids, taken together, span the entire CDC42 coding region. A possible explanation for this result is that the cdc42-1 allele actually contains two mutations, such that neither plasmid's insert contains the wildtype information corresponding to both mutant sites. This hypothesis is consistent with the observation that only the one cdc42 's mutant was isolated in a search that yielded multiple independent mutants for each of the related genes CDC24 and CDC43 (Adams et al., 1990) . Sequencing of the cdc42-1 allele should resolve this point.
Our results have provided some additional information about CDC42 function. First, the finding that overexpression of CDC42 can l~ad to mislocalization of budding sites suggests that the CDC42 product is involved in the initial selection of the budding site as well as in the subsequent emergence of the bud. Interestingly, the same inference has been made about the CDC24 product on the basis of mutants that display a similar mislocalization of budding sites (Sloat et al., 1981) . In addition, deletion of RSR/ (another ms-related gene that seems to be involved in bud emergence) produces a similar mislocalization of budding sites (Bender and Pringle, 1989) , and overproduction of ABP (actin-binding protein) 85 leads to a somewhat different abnormal pattern of budding (Drubin et al., 1988) . It seems possible that these proteins are involved in marking the site at which bud emergence should occur, and that mislocalization of an overproduced or abnormal protein can thus perturb the normal budding pattern. However, it also remains possible that the mislocalization of budding sites in these situations simply reflects a less specific cellular pathology (Hayashibe, 1975; Thompson and Wheals, 1980) . Second, the finding that the predicted CDC42 protein has substantial sequence similarity to the ras and rho families of proteins provides important, though limited, clues to its function at the molecular level. Much of this similarity is in the regions that have been implicated in the binding and hydrolysis of GTP. In this regard, it is relevant that the Aplysia rho gene product has been shown to bind and hydrolyze GTP after expression in E. coli (Anderson and Lacal, 1987) , and that the G25K protein (which shares with CDC42 an unusual feature in the putative GTP-binding site: see Results) binds guanine nucleotides avidly (Evans et al., 1986; Waldo et al., 1987; Polakis et al., 1988) . If the CDC42 product indeed also has GTP binding and hydrolysis activities (a point to be tested as soon as CDC42-specific antibodies are available), it is likely also to be involved in signal transduction of some sort. However, it is important to note that this biochemical motif has apparently been adapted to a wide variety of purposes in yeast. Confirmed or suspected GTP-binding/hydrolyzing proteins identified to date include the RAS1 and RAS2 products, implicated in the control of adenylate cyclase and hence (via the cAMP-dependent protein kinase) in the overall coordination of cell growth and macromolecular synthesis (Powers et al., 1984; Tatchell, 1986) ; the GS//product, which may be involved in the Gl-to-S phase transition (Kikuchi et al., 1988) ; the YFH product (Gallwitz et al., 1983 ), which appears to be localized to the Golgi apparatus (Segev et al., 1988) and is implicated in the control of secretion and Ca 2+ flux (Segev and Botstein, 1987; Wagner et al., 1987) ; the SEC4 product, which is involved in post-Golgi apparatus events of the secretory pathway (Salminen and Novick, 1987; Goud et al., 1988) ; the SCG1/GPA1 product, which appears to be involved in the pheromone response pathway (Dietzel and Kurjan, 1987; Miyajima et al., 1987) ; the GPA2 product, which may be involved in regulating cAMP levels (Nakafuku et al., 1988) ; the CIN4 product, which appears to be involved in ensuring normal chromosome transmission dur-ing mitosis (Steams, T., personal communication); the ARF/ and ARF2 gene products, which are similar to mammalian ADP-ribosylation factor (Sewell and Kahn, 1988) ; and the Rtt01 and RH02 products, whose function(s) are unknown but apparently distinct from those of the RAS1 and RAS2 products (Madaule et al., 1987) . There is no reason to think that this list is complete.
Thus, the critical step in elucidating CDC42 function is likely to be determining what signals are transduced, and by means of what downstream effectors. On these points we have as yet few clues. The extensive sequence similarities between the CDC42 product and the RHO gene products of yeast and animals suggests that there may be common aspects of function beyond GTP binding and hydrolysis. However, this clue is not too helpful until more is known of the function of the other RHO gene products. The similarity of cdc42 mutants to cdc24 mutants and the evidence that the CDC24 product is a Ca2+-interactive protein (Ohya et al., 1986a,b; Miyamoto et al., 1987) suggest that signal transduction by the CDC42 product may also involve Ca 2+, but there are no clues yet as to the nature of such possible involvement. Finally, the observation that the CDC42 product has COOH-terminal sequences similar to those at which ms and related proteins become modified by hydrophobic prosthetic groups (Clarke et al., 1988; Goodman et al., 1988; Molenaar et al., 1988; Hancock et al., 1989; Schafer et al., 1989) suggests that the CDC42 product also may be modified as a mechanism for attachment to the cell membrane. This is an attractive notion if, as suggested above, one function of the CDC42 product is to help mark the site on the cell surface at which the new bud should emerge.
